51²è¹Ý

Skip to main content
Skip to results
69 results sorted by Most viewed
  • Industry must notify the MHRA if they will not be using these flexibilities

  • Details of how Marketing Authorisation Holders can provide information on planned or potential future submissions, to the MHRA.

  • Apply now to join the AI Airlock pilot by the MHRA. Benefit from industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.

  • A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.

  • Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.

  • A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.

  • A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies

  • Applying for market authorisation for plasma master files (PMFs) and vaccine antigen master files (VAMFs).

  • MHRA scientific and regulatory advice for COVID-19 vaccine developers